Phase I study of high-dose epirubicin and vinorelbine in previously untreated non-small-cell lung cancer stage IIIB-IV.

por Bakker, M., Groen, H. J., Smit, E. F., Smeets, J., Riggi, M., Postmus, P. E.
Publicado 1995

Idarubicinol myelotoxicity: a comparison of in vitro data with clinical outcome in patients treated with high-dose idarubicin

por Corsini, C, Ghielmini, M, Mancuso, P, Tealdo, F, Paolucci, M, Zucchetti, M, Ferrucci, P F, Cocorocchio, E, Mezzetti, M, Mori, A, Riggi, M, D'Incalci, M, Martinelli, G
Publicado 2000